A Study to Assess the Reconstruction of the Ulnar Collateral Ligament of the Elbow in Non-Elite Athletes Using Allograft

Overview

About this study

The purpose of the study is to report the outcomes and complications for non-elite athletes who have undergone UCL ligament reconstruction using an allograft and to compare those results to patients who have undergone UCL ligament reconstruction using autograft from the literature

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Adult patient, 18 years or older.
Elbow Ulnar Collateral Ligment (UCL) reconstruction performed by Dr. Camp, Dr. O’Driscoll, Dr. Morrey or Dr. Sanchez-Sotelo.
Operation performed at Rochester Methodist Hospital.
Allograft tendon graft used.

Exclusion Criteria:

Simultaneous elbow Lateral Collateral Ligment (LCL) reconstruction.
Pediatric patient less than 18 years old at time of surgery.
Professional or elite amateur athlete (Olympic team).

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Christopher Camp, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Christopher Camp, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials